COVID-19, XBB, disease burden, medical resources, pharmaceutical intervention, non pharmaceutical intervention, modelling
novel coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, Delta variant, vaccination, transition of disease burden, children and adolescents, China